Literature DB >> 2702109

Cyclosporine induces abnormal facial bone growth in children: a preliminary study.

V M Reznik1, J S Berger, K L Jones, S A Mendoza.   

Abstract

Using cephalometric radiography, facial bony structure of a group of pediatric renal transplant recipients immunosuppressed with cyclosporine (CsA) and prednisone was studied and compared with a control group of children. A pattern of abnormal facial growth was demonstrated on cephalometry in eight of nine transplant recipients receiving CsA. The abnormalities included shortening of posterior facial height and increased anterior facial height with a deep mandibular plane angle. There was also an absolute shortening in the mandibular body and mandibular retrognathia. These findings may be consistent with inhibition of mandibular condylar growth inhibiting the anteroinferior growth of the mandible. Similar changes were present in two children with end-stage renal disease and none of the remaining nine control patients (P less than 0.01, chi-squared analysis). The affected area appears to be the lower third of the face. The role of CsA in affecting facial bony growth in children needs to be evaluated further.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2702109     DOI: 10.1007/BF00858534

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

1.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

Review 2.  Complications of cyclosporin therapy.

Authors:  B D Kahan; S M Flechner; M I Lorber; C Jensen; D Golden; C T Van Buren
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

3.  Contrasting mandibular growth and facial development in long face syndrome, juvenile rheumatoid polyarthritis, and mandibulofacial dysostosis.

Authors:  A Björk; V Skieller
Journal:  J Craniofac Genet Dev Biol Suppl       Date:  1985

4.  Normal and abnormal craniofacial growth. Some experimental and clinical considerations.

Authors:  B G Sarnat
Journal:  Angle Orthod       Date:  1983-10       Impact factor: 2.079

5.  Changes in facial dimensions and relationships between the ages of 5 and 25 years.

Authors:  S E Bishara; L C Peterson; E C Bishara
Journal:  Am J Orthod       Date:  1984-03

6.  Changes in facial appearance during cyclosporin treatment.

Authors:  V M Reznik; K L Jones; B L Durham; S A Mendoza
Journal:  Lancet       Date:  1987-06-20       Impact factor: 79.321

Review 7.  Action and toxicity of cyclosporine.

Authors:  W M Bennett; D J Norman
Journal:  Annu Rev Med       Date:  1986       Impact factor: 13.739

8.  Mandibular deficiency syndrome. I. Clinical delineation and therapeutic significance.

Authors:  L M Wolford; G Walker; S Schendel; L C Fish; B N Epker
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1978-03

9.  Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.

Authors:  W R Griswold; B M Tune; V M Reznik; M Vazquez; D J Prime; P Brock; S A Mendoza
Journal:  Nephron       Date:  1987       Impact factor: 2.847

10.  Use of cyclosporine in pediatric renal transplant recipients.

Authors:  S B Conley; S M Flechner; G Rose; C T Van Buren; E Brewer; B D Kahan
Journal:  J Pediatr       Date:  1985-01       Impact factor: 4.406

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.